MedicalSentry

Health Research Company

XYLOCAINE

generic name is Lidocaine Hydrochloride
Active Substance: LIDOCAINE HYDROCHLORIDE

XYLOCAINE Available Drugs :

XYLOCAINE ndc# 21695-466

by Rebel Distributors Corp

INFILTRATION INJECTION with active strength of 10 mg/mL

started marketing at 19/11/1948 .

Xylocaine ndc# 54868-1795

by Physicians Total Care, Inc.

INFILTRATION, PERINEURAL INJECTION, SOLUTION with active strength of 10 mg/mL

started marketing at 15/05/1995 .

Xylocaine ndc# 54868-1796

by Physicians Total Care, Inc.

INFILTRATION, PERINEURAL INJECTION, SOLUTION with active strength of .01, 10 mg/mL, mg/mL

started marketing at 15/05/1995 .

Xylocaine ndc# 54868-1798

by Physicians Total Care, Inc.

INFILTRATION, PERINEURAL INJECTION, SOLUTION with active strength of 20 mg/mL

started marketing at 09/11/1993 .

Xylocaine ndc# 55154-9388

by Cardinal Health

EPIDURAL, INFILTRATION, INTRACAUDAL, PERINEURAL INJECTION, SOLUTION with active strength of 20 mg/mL

started marketing at 12/08/2010 .

Xylocaine ndc# 55154-9565

by Cardinal Health

INFILTRATION, PERINEURAL INJECTION, SOLUTION with active strength of 5 mg/mL

started marketing at 12/08/2010 .

Xylocaine ndc# 55154-9566

by Cardinal Health

INFILTRATION, PERINEURAL INJECTION, SOLUTION with active strength of .01, 10 mg/mL, mg/mL

started marketing at 12/08/2010 .

Xylocaine ndc# 55154-9567

by Cardinal Health

INFILTRATION, PERINEURAL INJECTION, SOLUTION with active strength of .01, 20 mg/mL, mg/mL

started marketing at 12/08/2010 .

Xylocaine ndc# 55154-9568

by Cardinal Health

EPIDURAL, INFILTRATION, INTRACAUDAL, PERINEURAL INJECTION, SOLUTION with active strength of .005, 20 mg/mL, mg/mL

started marketing at 12/08/2010 .

Xylocaine ndc# 55154-9569

by Cardinal Health

INFILTRATION, PERINEURAL INJECTION, SOLUTION with active strength of 20 mg/mL

started marketing at 12/08/2010 .

Xylocaine ndc# 55154-9560

by Cardinal Health

EPIDURAL, INFILTRATION, INTRACAUDAL, PERINEURAL INJECTION, SOLUTION with active strength of 10 mg/mL

started marketing at 12/08/2010 .

Xylocaine ndc# 55154-9563

by Cardinal Health

INFILTRATION, PERINEURAL INJECTION, SOLUTION with active strength of 20 mg/mL

started marketing at 12/08/2010 .

XYLOCAINE ndc# 55154-9607

by Cardinal Health

TOPICAL JELLY with active strength of 20 mg/mL

started marketing at 16/07/2012 .

Xylocaine ndc# 76478-479

by Oak Pharmaceuticals, Inc. (Subsidiary of Akorn, Inc.)

TOPICAL JELLY with active strength of .5 mg/18mL

started marketing at 01/07/2012 .

Xylocaine ndc# 63323-489

by APP Pharmaceuticals, LLC

EPIDURAL, INFILTRATION, INTRACAUDAL, PERINEURAL INJECTION, SOLUTION with active strength of .005, 20 mg/mL, mg/mL

started marketing at 12/08/2010 .

Xylocaine ndc# 63323-488

by APP Pharmaceuticals, LLC

EPIDURAL, INFILTRATION, INTRACAUDAL, PERINEURAL INJECTION, SOLUTION with active strength of .005, 15 mg/mL, mg/mL

started marketing at 12/08/2010 .

Xylocaine ndc# 63323-487

by APP Pharmaceuticals, LLC

EPIDURAL, INFILTRATION, INTRACAUDAL, PERINEURAL INJECTION, SOLUTION with active strength of .005, 10 mg/mL, mg/mL

started marketing at 12/08/2010 .

Xylocaine ndc# 63323-486

by APP Pharmaceuticals, LLC

INFILTRATION, PERINEURAL INJECTION, SOLUTION with active strength of 20 mg/mL

started marketing at 12/08/2010 .

Xylocaine ndc# 63323-485

by APP Pharmaceuticals, LLC

INFILTRATION, PERINEURAL INJECTION, SOLUTION with active strength of 10 mg/mL

started marketing at 12/08/2010 .

Xylocaine ndc# 63323-484

by APP Pharmaceuticals, LLC

INFILTRATION, PERINEURAL INJECTION, SOLUTION with active strength of 5 mg/mL

started marketing at 12/08/2010 .

Xylocaine ndc# 63323-483

by APP Pharmaceuticals, LLC

INFILTRATION, PERINEURAL INJECTION, SOLUTION with active strength of .01, 20 mg/mL, mg/mL

started marketing at 12/08/2010 .

Xylocaine ndc# 63323-482

by APP Pharmaceuticals, LLC

INFILTRATION, PERINEURAL INJECTION, SOLUTION with active strength of .01, 10 mg/mL, mg/mL

started marketing at 12/08/2010 .

Xylocaine ndc# 63323-481

by APP Pharmaceuticals, LLC

INFILTRATION, PERINEURAL INJECTION, SOLUTION with active strength of .005, 5 mg/mL, mg/mL

started marketing at 12/08/2010 .

Xylocaine ndc# 63323-479

by APP Pharmaceuticals, LLC

TOPICAL JELLY with active strength of 20 mg/mL

started marketing at 27/09/2010 .

Xylocaine ndc# 63323-493

by APP Pharmaceuticals, LLC

EPIDURAL, INFILTRATION, INTRACAUDAL, PERINEURAL INJECTION, SOLUTION with active strength of 15 mg/mL

started marketing at 18/07/2011 .

Xylocaine ndc# 63323-496

by APP Pharmaceuticals, LLC

EPIDURAL, INFILTRATION, INTRACAUDAL, PERINEURAL INJECTION, SOLUTION with active strength of 20 mg/mL

started marketing at 18/07/2011 .

Xylocaine ndc# 63323-495

by APP Pharmaceuticals, LLC

EPIDURAL, INFILTRATION, INTRACAUDAL, PERINEURAL INJECTION, SOLUTION with active strength of 20 mg/mL

started marketing at 12/08/2010 .

Xylocaine ndc# 63323-498

by APP Pharmaceuticals, LLC

INTRAVENOUS INJECTION, SOLUTION with active strength of 20 mg/mL

started marketing at 11/11/2009 .

Xylocaine ndc# 63323-497

by APP Pharmaceuticals, LLC

TOPICAL SOLUTION with active strength of 40 mg/mL

started marketing at 11/11/2009 .

Xylocaine ndc# 63323-492

by APP Pharmaceuticals, LLC

EPIDURAL, INFILTRATION, INTRACAUDAL, PERINEURAL INJECTION, SOLUTION with active strength of 10 mg/mL

started marketing at 18/07/2011 .

Xylocaine ndc# 63323-491

by APP Pharmaceuticals, LLC

INFILTRATION INJECTION, SOLUTION with active strength of 5 mg/mL

started marketing at 12/08/2010 .

Xylocaine ndc# 66312-181

by Dentsply Pharmaceutical

SUBCUTANEOUS INJECTION, SOLUTION with active strength of 20, 20 ug/mL, mg/mL

started marketing at 22/01/1985 .

Xylocaine ndc# 66312-176

by Dentsply Pharmaceutical

SUBCUTANEOUS INJECTION, SOLUTION with active strength of 10, 20 ug/mL, mg/mL

started marketing at 22/01/1985 .

Xylocaine ndc# 52584-484

by General Injectables & Vaccines, Inc

INFILTRATION, PERINEURAL INJECTION, SOLUTION with active strength of 5 mg/mL

started marketing at 21/09/2011 .

Xylocaine ndc# 52584-483

by General Injectables & Vaccines, Inc

INFILTRATION, PERINEURAL INJECTION, SOLUTION with active strength of .01, 20 mg/mL, mg/mL

started marketing at 03/11/2011 .

Xylocaine ndc# 52584-482

by General Injectables & Vaccines, Inc

INFILTRATION, PERINEURAL INJECTION, SOLUTION with active strength of .01, 10 mg/mL, mg/mL

started marketing at 12/09/2011 .

Xylocaine ndc# 52584-481

by General Injectables & Vaccines, Inc

INFILTRATION, PERINEURAL INJECTION, SOLUTION with active strength of .005, 5 mg/mL, mg/mL

started marketing at 28/09/2011 .

Xylocaine ndc# 52584-489

by General Injectables & Vaccines, Inc

EPIDURAL, INFILTRATION, INTRACAUDAL, PERINEURAL INJECTION, SOLUTION with active strength of .005, 20 mg/mL, mg/mL

started marketing at 27/09/2011 .

Xylocaine ndc# 52584-486

by General Injectables & Vaccines, Inc

INFILTRATION, PERINEURAL INJECTION, SOLUTION with active strength of 20 mg/mL

started marketing at 09/11/2011 .

Xylocaine ndc# 52584-485

by General Injectables & Vaccines, Inc

INFILTRATION, PERINEURAL INJECTION, SOLUTION with active strength of 10 mg/mL

started marketing at 25/10/2011 .

XYLOCAINE Search Trends:

News :

Social Buzz

comments powered by Disqus